Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefotaxime vs Ceftriaxone vs Ciprofloxacin for SBP in Cirrhosis
NCT01265173Phase 4Completed
- Sponsor
- Korea University
- Start
- Apr 2007
- Primary completion
- Jun 2018
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone, ciprofloxacin in spontaneous bacterial peritonitis (SBP), sponsored by Korea University. Started Apr 2007; status: completed.
02
Drugs
ceftriaxoneciprofloxacin
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT01265173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01265173.